Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Raze Therapeutics
25 First Street, Suite 303
Cambridge, MA 02141
Phone: 617-588-2600
http://www.razetx.com/

Raze Therapeutics is dedicated to the discovery and development of a new class of oncology therapeutics that target fundamental metabolic pathways essential to cancer growth and survival. By selectively targeting one-carbon (1C) metabolism using its proprietary platform, Raze is developing a pipeline of 1C metabolism therapeutics across a range of solid and hematologic cancers, including genetically-defined cancers. Raze is led by an experienced management team with a proven track record for building successful biotech companies and recognized scientific leaders in metabolism and cancer biology.

Key Contact
Name
Jason Rhodes
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
10/14/14 $24,000,000 Series A Astellas Venture Management
Atlas Venture
MPM Capital
MS Ventures
Novartis Venture Funds
Partners Innovation Fund
undisclosed